Intended for healthcare professionals


NICE recommends genetic test to prevent deafness from antibiotics in newborn babies

BMJ 2023; 380 doi: (Published 09 February 2023) Cite this as: BMJ 2023;380:p325
  1. Zosia Kmietowicz
  1. The BMJ

A genetic test to establish whether a newborn baby is vulnerable to deafness if treated with gentamicin has been recommended in draft guidance by the National Institute for Health and Care Excellence (NICE).1

The Genedrive kit works by detecting the m.1555A>G variant from a swab of DNA from inside a newborn’s cheek, with results available in under an hour. If the m.1555A>G variant is found the baby can be treated with alternative antibiotics, which cannot be more widely used because of antibiotic resistance.

At present laboratory testing would not …

View Full Text

Log in

Log in through your institution


* For online subscription